PAG
ABBV icon

Private Advisor Group’s AbbVie ABBV Stock Holding History

Private Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,100
Closed -$22.5K – 2250
2023
Q3 		$22.5K Buy
+15,100
New +$2.22M ﹤0.01% 2097

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Private Advisor Group's ABBV Position: Q2 2026 in Review

Private Advisor Group reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $7.11M and leaving 233,214 shares worth $58.7M. The position accounts for 0.27% of the portfolio, ranked #70.

Private Advisor Group first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $84.8M in Q4 2024. 1,880 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Private Advisor Group held 233,214 shares of AbbVie worth $58.7M as of Q2 2026.
  • Private Advisor Group sold 33,032 AbbVie shares in Q2 2026, an estimated $7.11M.
  • AbbVie made up 0.27% of Private Advisor Group's portfolio in Q2 2026, its #70 holding.
  • Private Advisor Group first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's AbbVie position peaked at $84.8M in Q4 2024.
  • 1,880 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.